2026-09-25 · 2026-09 / week-4

Costco’s strong quarter does not make its premium a short catalyst

Costco’s strong quarter does not make its premium a short catalyst

Summary: Costco’s FY2026 results were strong, but the new tariff-refund benefit contributed only $0.15 of Q4 diluted EPS. At the September 24 close of $896.48, the stock traded at about 43.5 times FY2026 EPS excluding that benefit. A transparent multiple-compression sensitivity produces only a 3.4% base-case decline and an 8.1% adverse rise. The short fails the Desk’s 10/5 test; this is a no-trade screen, not a short recommendation.

Research timestamp: September 25, 2026, 16:44 Singapore time (08:44 UTC). The latest completed U.S. regular-session quote reviewed is the September 24 close. Costco released results after that close. A pre-market quote observed at 04:19 EDT is reference-only; no current executable quote or borrow terms were verified.

Opportunity Ranking

Rank Candidate Direction Mispricing Evidence Freshness Catalyst Window Positioning 10/5 Status Tradeability Main Rejection Risk
1 Costco (COST) Short screen Strong growth and high retention versus a 43.5x adjusted trailing multiple; no fresh operating break supports compression FY2026 release Sep. 24; Sep. 24 regular close Next monthly sales release and next quarterly report; exact dates not verified Current short interest, borrow, options and fund flows not verified Highly liquid Nasdaq common, but live quote, locate, borrow and exit gates are missing Strong comps and member growth can sustain or expand the premium; model base decline is only 3.4%
2 Forward Industries (FWDI) Short screen New equity issuance could be framed as dilution, but proceeds are intended for SOL and may raise SOL per share Offering closed Sep. 24; holdings update Sep. 21; latest close Sep. 24 Deployment of proceeds and next holdings/denominator update No current borrow or direct short-positioning evidence Volatile Nasdaq common; current spread, depth, locate and borrow unverified The $8 issue price is below the $8.35 close, but the stock recovered above it and the planned asset purchase can be accretive per share
3 Darden Restaurants (DRI) Short screen Olive Garden’s 1.1% comparable-sales growth lagged LongHorn’s 6.8%, but total comps and the FY27 EPS guide were positive/reaffirmed Q1 FY2027 release Sep. 24; close Sep. 24 Next quarterly brand-mix and margin report Direct short/borrow/options data unavailable Liquid NYSE common; no current execution audit Stronger LongHorn and other brands can offset Olive Garden weakness; the brand-mix gap does not bound downside risk

Selected opportunity: COST, for information value only. It is not the best executable short.

Why this one now: The fresh release permits a clean earnings-quality adjustment and a current market-price comparison. It also makes the countercase unusually strong: adjusted comparable sales grew 6.7%, digitally enabled comparable sales grew 19.8%, and FY diluted EPS rose 14.0%.

What should surprise the reader: The most short-friendly number is not the tariff refund. Removing the disclosed $0.15 from $20.76 FY EPS leaves $20.61, so the stock still costs about 43.5 times that adjusted denominator. Yet the refund is only 0.7% of annual EPS, while the release reports healthy sales and comp growth. Expensive is not the same as mispriced, and neither alone supplies a dated downward catalyst.

Why This Is the Best Opportunity Right Now

This is a ranking of short-side research value, not an assertion that any candidate qualifies. COST ranks first because its just-reported results supply a falsifiable earnings-and-multiple bridge. FWDI’s financing headline looks more directly bearish but is structurally ambiguous: the issuer says the net proceeds will primarily buy SOL, so the key test is asset growth per share after fees and deployment, not gross shares issued alone. DRI offers a real brand divergence, but its Q1 release also showed 3.2% comparable sales and reaffirmed FY27 EPS guidance of $11.10-$11.35. Those competing facts make a short less clean than the Olive Garden headline suggests.

The strongest counterargument against a COST short is that the operating evidence supports a premium: reported Q4 sales grew 11.2%, adjusted comps 6.7%, digital comps 19.8%, and annual diluted EPS 14.0%. Membership-fee revenue rose to $5.907 billion from $5.323 billion. The case for caution is narrower: the price embeds a high multiple, there is no numeric FY27 guide in the release, and the next results must maintain growth while the one-off Q4 tariff refund drops out of the comparison. That is a valuation sensitivity, not yet a catalyst-backed mispricing.

Why This Can Move More Than 5% Soon

At roughly 43.5 times FY2026 EPS excluding the tariff refund, a 10% price decline with earnings unchanged would require a multiple near 39.1 times. The six-month downside case below reaches that threshold only in the top short case, at 39 times earnings. But the same sensitivity allows a 47-times premium outcome, an 8.1% rise before any short borrow, recall, dividend, spread or slippage costs. The next monthly sales report can test demand, but the date and surprise are not established here. A possible valuation reset is not the same as an identified event that makes the reset more likely than continuation.

10/5 Asymmetry Gate

Test Reference-only result from $896.48
Favorable base-case decline 3.4%
Credible adverse rise 8.1%
Gross base reward / adverse risk 0.43:1
Probability-weighted gross short return Approximately +1.4% before costs
Classification Reject / no trade

The base case misses the required 10% decline; the adverse case exceeds the 5% rise limit; and the gross ratio is below 2:1. A 2.5% six-month borrow cost at a hypothetical 5% annualized rate would more than erase the modeled 1.4% gross expected return. Actual borrow availability, fee, rebate and recall terms are unknown, so this sensitivity is illustrative, not a quote.

The Setup

Fact: Costco’s 16-week Q4 FY2026 net sales rose 11.2% to $93.9 billion. Q4 comparable sales grew 9.4% reported and 6.7% after adjustment for gasoline and foreign exchange. Digital comparable sales rose 19.8%. Annual net sales rose 10.1% and diluted EPS rose to $20.76 from $18.21. The company disclosed that a non-recurring $0.15 per-share tariff-refund benefit helped Q4 EPS.

Inference: The reported EPS growth overstates recurring Q4 earnings by $0.15 per diluted share, but that adjustment is too small to carry a short thesis by itself. Annual EPS excluding it is approximately $20.61, and the market price is about 43.5 times that figure. This static multiple does not account for future earnings growth, capital returns or a change in the quality of Costco’s membership economics.

Unknown: The release does not provide a numerical FY2027 EPS outlook. Current valuation consensus, short interest, securities-lending inventory, borrow cost/recall, options positioning and post-result fund flows were not verified. I do not have sufficient reliable data to quantify how much of the premium is explained by forward earnings expectations or how crowded a short would be.

The Market Price

The latest completed regular-session close reviewed was $896.48 at 4:00 p.m. EDT on September 24, with 2.72 million shares reported by S&P Global Market Intelligence through StockAnalysis. Costco’s earnings release followed after that close. StockAnalysis displayed a $894.49 pre-market observation at 4:19 a.m. EDT on September 25; it is not a regular-session acceptance price and is not used as an entry. Another historical vendor showed $896.02 for the regular close, a $0.46 discrepancy. The model retains the S&P-attributed $896.48 reference and remains non-executable.

The 10/5 valuation sensitivity uses $20.61 FY2026 EPS, calculated as issuer-reported $20.76 diluted EPS less the disclosed $0.15 tariff refund. It uses analyst-assumed 39x, 42x and 47x multiples, not a DCF, company guidance, or observed forward multiple. The base multiple is near today’s adjusted trailing multiple; the top case requires contraction, and the bottom case allows continued premium expansion. This intentionally exposes how little the short case gains from the one-time EPS item alone.

The Mispricing

The possible disagreement is whether Costco’s quality deserves a persistent premium above 40 times trailing adjusted earnings, or whether the market will demand faster earnings growth to support that price. The $0.15 tariff refund is a real non-recurring item, but it is about 0.7% of full-year EPS. The release’s broad comp and digital growth are evidence against an immediate earnings break. No primary evidence reviewed shows that demand, membership retention, margins or guidance have rolled over.

The market could be wrong if future growth decelerates while the multiple remains priced for durability. It could also be right if warehouse openings, member additions, renewal economics and digital growth continue to compound. The current evidence supports monitoring the premium, not betting against the business.

The Positioning

The September 24 regular-session volume was about 2.72 million shares, but volume does not identify who bought or sold. This run did not verify settlement-dated short interest, utilization, borrow availability, rebate/fee, recall terms, options open interest, dealer exposure or fund flows. Positioning is therefore unknown, not “crowded” by inference from valuation or one session’s volume.

The Catalyst

  1. Next monthly sales release: compare reported and adjusted comparable sales by geography, traffic, digital sales and any disclosed membership data. The next release date was not verified in the issuer materials reviewed.
  2. Next quarterly results: test whether sales and membership-fee growth convert into earnings and whether the tariff-refund contribution has rolled out of the comparison. Do not treat a single monthly comp as proof of a margin or EPS break.
  3. Cheapest falsification test: if the next release maintains mid-to-high-single-digit adjusted comps and annualized earnings growth without a guide cut, the near-term short catalyst is absent. If comps materially slow across regions and the company cuts its outlook, rebuild the valuation from fresh consensus and a fresh regular-session price.

The Payoff

The scenario map holds FY2026 EPS excluding the $0.15 refund at $20.61 and varies only the assumed P/E multiple. The horizon is six months, through the next two monthly sales releases and the next quarterly report; no exact report dates are assumed. Probabilities of 20%/50%/30% are subjective analyst weights for multiple contraction / roughly stable valuation / further premium expansion, not observed frequencies. The expected value is a price sensitivity, not a forecast with statistical calibration.

Scenario Probability Target / Level Return / Payoff from $896.48 Horizon Conditions Evidence Quality
Top Case 20% $803.79 -10.3% underlying; favorable short Six months 39x $20.61 EPS; future sales slow enough to compress the premium Low: no current operating break or forward EPS estimate supports this multiple
Base Case 50% $865.62 -3.4% underlying; favorable short Six months 42x $20.61 EPS; quality premium largely persists Medium-low: current adjusted trailing multiple is about 43.5x, but this is a static-EPS assumption
Bottom Case 30% $968.67 +8.1% underlying; adverse squeeze Six months 47x $20.61 EPS; durable comps and member economics preserve or extend the premium Medium-low: strong current growth supports resilience; 47x is an explicit stress assumption
Invalidation n/a No price stop Thesis invalid if adjusted comps and EPS growth remain robust and premium valuation is sustained; short remains unsuitable At each monthly/quarterly update The operating evidence improves or holds while no estimate reset emerges Medium

Probability-weighted expected value: $884.17, approximately +1.4% gross short return from the reference, before borrow, dividends, fees, spread, slippage and path risk.

Current market level and timestamp: $896.48 regular close, Sep. 24, 2026, 4:00 p.m. EDT; reference only.

Primary instrument: None; no trade.

10/5 favorable base move: 3.4% decline.

10/5 credible adverse move: 8.1% rise.

10/5 measurement basis: reference-only, not verified entry.

10/5 status: Reject.

Confidence: Low on valuation outcomes; high that this modeled map fails the Desk hurdle.

Sensitivity is unfavorable to the short: the 10% decline threshold requires about 39.1x unchanged adjusted FY2026 EPS, close to the model’s top case rather than its base. A 5% adverse cap corresponds to approximately 45.7x on the same EPS; the 47x bottom case exceeds it. Any borrow and carrying costs make the already-small gross expectation worse.

The Kill Shot

Strongest counterargument: Costco’s price is not supported by a one-quarter story alone. Annual sales grew 10.1%, adjusted annual comps grew 6.6%, digital comps grew 20.7%, and annual EPS grew 14.0%. Membership fees are recurring and rose 11.0%. Those facts can sustain premium valuation even when a quarter contains a small one-off benefit.

Load-bearing assumption: The short needs a valuation multiple near 39x or lower without a comparable EPS deterioration. No evidence in this run establishes that investors are about to abandon Costco’s quality premium. If earnings grow, a stable or expanding multiple can overwhelm the tariff adjustment.

How the trade loses even if valuation is eventually right: a premium stock can rise or remain elevated for longer than borrow economics permit; an upward gap can exceed any chosen stop; locate recall can force an exit; and a broad-market rally can lift the stock before the next catalyst. The modeled adverse case already breaches the Desk’s 5% bound.

What Could Go Wrong

The multiple assumptions may not resemble the market’s forward valuation framework. Static FY2026 EPS understates future earnings if growth continues and may overstate them if tariff refunds, traffic or margins prove more important than the release suggests. The cost of borrow, dividends, execution spread, slippage and recall are unknown. Price targets are not price floors; a short’s loss is theoretically unbounded.

What Would Prove This Wrong

For the bearish valuation concern, the cheapest disconfirming evidence is sustained adjusted comps and membership-fee growth in the next sales/results releases alongside maintained or rising earnings estimates. For a future short thesis, the minimum new evidence would be a material operating or estimate deterioration, a dated catalyst, a model whose highest-probability case clears a 10% decline while the credible squeeze case stays within 5%, and verified locate/borrow and live execution conditions.

Risk Audit

Risk Assessment
Operating risk to short thesis High: current sales/comps/EPS trends are strong
Valuation-model risk High: multiples are assumptions; no current forward consensus bridge was verified
Positioning / borrow Unknown: no live locate, fee, recall, utilization or flow evidence
Gap and event risk High: monthly sales and results can reprice the stock before a short can exit
Liquidity and exits Regular volume is substantial, but this run did not verify current spread, depth, venue or short-size capacity
Carry and path risk Material: any positive expected return is small relative to possible adverse mark-to-market and borrow costs

Best Trade Strategy

No trade. Keep entry.price=null; the paired signal remains watch solely as research context and sets execution.can_execute=false. Do not short common stock without a newly passing 10/5 map and verified locate, borrow cost/recall terms, regular-session quote, spread, depth, volume quality and exit capacity. No options, leverage, margin, market orders or price-floor language.

Sources

  1. Costco Q4 and FY2026 operating results, issuer release, Sep. 24, 2026. Primary source for sales, comparable sales, tariff-refund EPS effect and annual results.
  2. COST Sep. 24 historical prices, S&P Global Market Intelligence attribution, accessed Sep. 25, 2026. Reference close, session time and volume; the site also displayed a Sep. 25 pre-market observation.
  3. Forward Industries completes $25M registered direct offering, issuer release, Sep. 24, 2026. Primary source for shares issued, $8 price, gross proceeds and intended use of net proceeds.
  4. Forward Industries’ SOL holdings rise to approximately 8.16M SOL, issuer release, Sep. 21, 2026. Issuer-reported holding snapshot, including preliminary/unaudited caveats.
  5. Forward Industries Q2 FY2026 Form 10-Q, filed Aug. 2026. Primary source for debt, pledged SOL, ATM capacity, warrants, repurchases and historical shares; the June 30 denominator is not a current post-offering count.
  6. FWDI Sep. 24 historical prices, market-data source, accessed Sep. 25, 2026. Regular-session close and volume.
  7. Darden Q1 FY2027 results, issuer release, Sep. 24, 2026. Primary source for comparable sales by brand and reaffirmed FY27 EPS outlook.

Research Quality Scorecard

Criterion Score Evidence and deduction
Market disagreement 3/5 A premium multiple conflicts with modest one-off-adjusted EPS, but no operating break is established
Evidence base 5/5 Fresh issuer results and attributed close directly support the operating/EPS adjustment and reference price; the missing forward estimate bridge is a scope limitation, not a source-quality defect
Positioning and flows 1/5 Current short, borrow, options, dealer and fund-flow data are missing
Catalyst path 3/5 Monthly sales and the next quarter are observable tests, but dates and a negative catalyst are unverified
Payoff architecture 3/5 EPS/multiple sensitivity and cost break-even are explicit, but the multiples are assumptions rather than a forward valuation bridge
Invalidation discipline 4/5 Monthly comps, membership fees and quarterly EPS can disconfirm a short thesis
Differentiated insight 3/5 The one-time refund is quantified against annual EPS; it is too small to explain the premium by itself
Client value 4/5 Separates a real valuation concern from an unsupported trade and shows the squeeze/carry asymmetry
Total 26/40 Short note / no-trade screen; the 10/5 failure still rejects publication as a trade

Bottom Line

Costco is expensive on a static trailing measure, but its newly reported operating results do not show a break, and the tariff-refund benefit is less than 1% of annual EPS. Under an explicit, assumption-heavy valuation sensitivity, the base short gain is 3.4%, the adverse rise is 8.1%, and gross expected return is about 1.4% before costs. That does not meet the Desk’s asymmetry standard. Keep COST on a valuation watchlist; do not short it on this evidence.

AI Illustration Prompt

Create a restrained financial-journalism illustration of Costco (NASDAQ: COST) after FY2026 results. Show a warehouse membership receipt with verified operating results prominently: “FY26 SALES +10.1%,” “ADJUSTED Q4 COMPS +6.7%,” “DIGITAL Q4 COMPS +19.8%,” “FY26 DILUTED EPS $20.76.” Isolate a small amber line item “Q4 TARIFF REFUND +$0.15 / NON-RECURRING,” then calculate “ADJUSTED TRAILING EPS ~$20.61.” On a valuation scale, place the market reference “$896.48 / ~43.5x ADJUSTED FY26 EPS” between “39x / $803.79 / TOP SHORT CASE -10.3%” and “47x / $968.67 / ADVERSE +8.1%”; center “42x / $865.62 / BASE DECLINE 3.4%.” Stamp the center “REJECT / NO TRADE — 10/5 FAILS.” Add a discreet note “BORROW, RECALL AND LIVE DEPTH UNVERIFIED.” Use warehouse-paper cream, graphite, deep navy and a restrained amber accent, clean editorial lighting, no generic candlesticks, no invented logos, with a subtle readable “The Mispricing Desk” watermark. Wide 16:9.